Marius Pearson
For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.
Oxford PharmaGenesis is proud to sponsor the latest CISCRP clinical trials education campaign to raise awareness and understanding of clinical research among minority urban communities in cities across the USA and among the wider general public.
Oxford PharmaGenesis has been shortlisted for the Communiqué Awards 2022 for the Award for Excellence in Public Health Communications for MS Brain Health, on behalf of Oxford Health Policy Forum. This global policy initiative has changed the way that leading multiple sclerosis (MS) experts view best practice in MS care.
Citation (title and abstract) screening for a systematic literature review may be accelerated by 25% through the application of artificial intelligence (AI) in a novel method developed by Oxford PharmaGenesis in partnership with Vyasa. The evidence reported in systematic literature reviews derives from articles that have passed a rigorous screening process. According to a recent study, our new, […]
Creativity, diversity, data visualization and plain language summaries all took centre stage at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 9–11 May 2022 in Washington, DC, USA.
Share this page As study finds that 95% of the top pharmaceutical companies worldwide aim to cut greenhouse gas emissions, commitments will require innovation and collaboration across the supply chain. Washington, DC, USA, 10 May 2022: According to a study presented at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) today, 19 […]
Oxford PharmaGenesis is proud to sponsor the MAPS 2022 EMEA Annual Meeting – the largest annual convention for Medical Affairs professionals in Europe, the Middle East and Africa. We are an award-winning, independent, global HealthScience consultancy. We take clients to new places with a range of transformative services. Our teams use innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.
We’re helping medical publication professionals become future-ready at the 18th Annual Meeting of ISMPP 2022. Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration and Open Pharma.
Our Informatics and Data Science team has developed a paper, in collaboration with authors from Pfizer, that details a novel approach to identifying emerging cancer biomarkers. The paper, recently published in the journal Cancer Informatics, is accompanied by a publicly accessible, interactive dashboard to allow users to explore new insights around emerging biomarkers.
Oxford PharmaGenesis is proud to sponsor the MAPS 2022 conference – the largest gathering of Medical Affairs professionals globally. We are an award-winning independent, global HealthScience communications consultancy. We take clients to new places with a range of transformative services. Our team uses innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.
